Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.

ABSTRACT:

Objectives

This study aimed to provide real-world data on the characteristics and treatment of patients with multiple myeloma (MM) at the time of death.

Methods

The study was a retrospective patient chart review across France, Germany, Italy, Spain and the UK during 2016, and included patients who had died in the 3 months before the index date.

Results

Data from 786 patients were reviewed. At the time of death, 37% of patients were receiving active treatment, 12% were in a treatment-free interval and 51% were receiving only supportive care. Death before and during active first-line treatment was not uncommon (6% and 24% of patients, respectively) but these deaths were often not solely due to disease progression; factors such as renal failure and infection frequently p

SUBMITTER: Mohty M 

PROVIDER: S-EPMC6851592 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature